Charles McWherter, SVP & Chief Scientific Officer at CymaBay Therapeutics, Inc. (CBAY), bought 5,000 shares at $8.67 ($43K) on 2017-11-02, disclosed to the SEC on 2017-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.67 | 300 | $3K | 6.0% |
| 2 | $8.67 | 4,700 | $41K | 94.0% |
| Total | $8.67 avg | 5,000 | $43K | 100% |
| Filing → |
| CBAY | SELL | 2024-01-22 | $752K | — | Filing → |
| CBAY | SELL | 2023-12-18 | $487K | — | Filing → |
| CBAY | SELL | 2023-11-17 | $415K | — | Filing → |